Endoscopic Devices - Israel

  • Israel
  • Revenue in the Endoscopic Devices market market in Israel is projected to reach US$166.40m in 2024.
  • Revenue in this market is expected to demonstrate an annual growth rate (CAGR 2024-2029) of 7.49%, leading to a market volume of US$238.80m by 2029.
  • In a global context, the highest revenue is anticipated to be generated the United States, with an expected figure of US$10,390.00m in 2024.
  • Israel's innovative healthcare landscape is driving significant advancements in endoscopic devices, enhancing minimally invasive procedures and improving patient outcomes.

Key regions: Italy, United Kingdom, Netherlands, Germany, Japan

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Endoscopic Devices Market in Israel is witnessing moderate growth, influenced by factors such as technological advancements, increasing healthcare investments, and a rising demand for minimally invasive procedures among medical professionals and patients alike.

Customer preferences:
Consumers in Israel are increasingly favoring minimally invasive surgical options, driving demand for advanced endoscopic devices. This shift is partly influenced by a growing awareness of the benefits of shorter recovery times and reduced pain associated with such procedures. Additionally, the aging population seeks efficient healthcare solutions that prioritize quick return to daily activities. Furthermore, cultural attitudes towards health and wellness are evolving, with a focus on preventive care, prompting healthcare providers to adopt innovative endoscopic techniques that align with these consumer preferences.

Trends in the market:
In Israel, the Endoscopic Devices Market is experiencing notable growth driven by the increasing preference for minimally invasive surgical procedures among patients. This trend is fueled by heightened awareness of the advantages these procedures offer, such as quicker recovery times and reduced postoperative pain. As the population ages, there is a growing demand for efficient healthcare solutions that support rapid reintegration into daily life. Moreover, evolving cultural attitudes towards preventive care are encouraging healthcare providers to adopt cutting-edge endoscopic techniques, presenting significant opportunities for industry stakeholders to innovate and expand their offerings.

Local special circumstances:
In Israel, the Endoscopic Devices Market is thriving, influenced by a highly developed healthcare infrastructure and a strong emphasis on technological innovation. The country's strategic geographic location fosters collaboration between leading medical research institutions and startups, facilitating rapid advancements in endoscopic technologies. Additionally, cultural factors such as a focus on preventive care and patient-centered approaches drive demand for minimally invasive procedures. Regulatory support from the Israeli Ministry of Health, which encourages the adoption of advanced medical technologies, further strengthens the market's growth potential.

Underlying macroeconomic factors:
The Endoscopic Devices Market in Israel is significantly shaped by macroeconomic factors such as robust healthcare spending, innovation-driven economic policies, and a rising demand for advanced medical technologies. The nation’s strong GDP growth and fiscal support for research and development create a conducive environment for the growth of endoscopic innovations. Additionally, Israel's emphasis on high-quality healthcare services and a growing elderly population are propelling demand for minimally invasive procedures. Global economic trends, including increased healthcare investment and the need for cost-effective treatment options, further enhance the market's expansion potential.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)